Toth Financial Advisory Corp reduced its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 104,499 shares of the pharmacy operator’s stock after selling 5,464 shares during the period. Walgreens Boots Alliance accounts for about 1.5% of Toth Financial Advisory Corp’s holdings, making the stock its 19th biggest position. Toth Financial Advisory Corp’s holdings in Walgreens Boots Alliance were worth $6,612,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in WBA. Massey Quick Simon & CO. LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $27,000. Murphy Pohlad Asset Management LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $29,000. Cornerstone Advisors Inc. grew its position in shares of Walgreens Boots Alliance by 102.4% during the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 214 shares during the last quarter. PRW Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $34,000. Finally, Nalls Sherbakoff Group LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $42,000. Institutional investors own 63.07% of the company’s stock.

In other news, COO Ornella Barra purchased 18,000 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The stock was acquired at an average price of $54.56 per share, with a total value of $982,080.00. Following the purchase, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 15.73% of the company’s stock.

WBA has been the topic of a number of research reports. BidaskClub lowered shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 18th. Wolfe Research restated a “peer perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, December 19th. Robert W. Baird lowered their target price on shares of Walgreens Boots Alliance from $71.00 to $70.00 and set a “neutral” rating on the stock in a research report on Friday, December 21st. Loop Capital set a $82.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, December 20th. Finally, Needham & Company LLC upgraded shares of Walgreens Boots Alliance to a “buy” rating and set a $94.00 target price on the stock in a research report on Thursday, December 20th. Five analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $68.50.

NASDAQ:WBA traded up $0.79 during midday trading on Monday, reaching $54.24. The stock had a trading volume of 5,953,271 shares, compared to its average volume of 6,727,794. Walgreens Boots Alliance Inc has a 12-month low of $53.32 and a 12-month high of $86.31. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. The firm has a market cap of $48.86 billion, a price-to-earnings ratio of 9.01, a price-to-earnings-growth ratio of 1.09 and a beta of 0.86.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 EPS for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). The business had revenue of $34.53 billion during the quarter, compared to analyst estimates of $34.57 billion. Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. Walgreens Boots Alliance’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $1.73 EPS. As a group, analysts expect that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-holdings-reduced-by-toth-financial-advisory-corp/2964542.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: What is an Initial Public Offering (IPO)?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.